948.5000 4.55 (0.48%)
NSE Sep 03, 2025 09:35 AM
Volume: 2,004
 

948.50
0.48%
Deven Choksey
We maintain a positive FY26E outlook, expecting sustained double-digit growth across US, Ex-US, and RoW businesses. Growth across regions will be majorly driven by a healthy US pipeline, strategic expansion in RoW, and improved execution across India.
Alembic Pharmaceuticals Ltd. has gained 27.55% in the last 6 Months
More from Alembic Pharmaceuticals Ltd.
Recommended